Is a SUV cut-off necessary in the evaluation of the response of axillary lymph node metastases to neoadjuvant therapy?
Gilardi
Laura
L
Paganelli
Giovanni
G
D001692:Biological Transport; D001943:Breast Neoplasms / Q000175:diagnosis / Q000378:metabolism / Q000473:pathology* / Q000628:therapy*; D019788:Fluorodeoxyglucose F18 / Q000378:metabolism; D006801:Humans; D008207:Lymphatic Metastasis; D020360:Neoadjuvant Therapy; D049268:Positron-Emission Tomography; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
D019788:Fluorodeoxyglucose F18
J Clin Oncol. 2005 Apr 20;23(12):2694-702
15837984
J Nucl Med. 2009 May;50 Suppl 1:55S-63S
19380410
Eur J Nucl Med Mol Imaging. 2010 Jun;37(6):1069-76
20130860
Eur J Nucl Med Mol Imaging. 2010 Oct;37(10):1834-41
20533032